Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Daiken Biomedical CoTPE:7780 +0.29%23 Receivables Turnover is 5.42 as of Dec. 2025. GuruFocus rates TPE:7780 with a GF Score™ of 23/100. The stock has 6 warning signs investors should review. Among 1,946 Consumer Packaged Goods companies, Daiken Biomedical Co ranks better than 76.52% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Daiken Biomedical Co's Revenue for the
three
months ended in Dec. 2025 was NT$656 Mil. Daiken Biomedical Co's average Accounts Receivable for the
three
months ended in Dec. 2025 was NT$121 Mil.
Hence, Daiken Biomedical Co's Receivables Turnover for the
three
months ended in Dec. 2025 was 5.42.
Daiken Biomedical Co (TPE:7780) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Daiken Biomedical Co Receivables Turnover Related Terms
Daiken Biomedical Co Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Daiken Biomedical Co's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:7780 vs KHC, GIS: Receivables Turnover Comparison
For the Packaged Foods subindustry, Daiken Biomedical Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daiken Biomedical Co Receivables Turnover vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Daiken Biomedical Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Daiken Biomedical Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daiken Biomedical Co (TPE:7780) has a Receivables Turnover of 5.42 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Daiken Biomedical Co and its competitors. According to the industry distribution chart, Daiken Biomedical Co ranks #457 out of 1946 companies in the Consumer Packaged Goods industry, placing it in the top 23.5%.
Is Daiken Biomedical Co's Receivables Turnover too high?
Daiken Biomedical Co's current Receivables Turnover is 5.42. The Consumer Packaged Goods industry median Receivables Turnover is 9.33. Daiken Biomedical Co's value of 5.42 is 41.9% below this industry median. Based on the distribution chart, Daiken Biomedical Co ranks #457 out of 1946 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Daiken Biomedical Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Daiken Biomedical Co's Receivables Turnover compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Daiken Biomedical Co ranks #457 out of 1946 companies for Receivables Turnover. This places Daiken Biomedical Co in the top 24% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 9.33. Daiken Biomedical Co's value of 5.42 is 41.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Consumer Packaged Goods company?
The median Receivables Turnover among Consumer Packaged Goods companies is 9.33, based on 1,946 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Daiken Biomedical Co's current Receivables Turnover of 5.42 is 41.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Daiken Biomedical Co and its competitors. For the Consumer Packaged Goods industry, the median Receivables Turnover is 9.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daiken Biomedical Co's current Receivables Turnover is 5.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiken Biomedical Co stock overvalued right now?
Daiken Biomedical Co (TPE:7780) has a current Receivables Turnover of 5.42. The current Receivables Turnover is 5.42 and 41.9% below the Consumer Packaged Goods industry median of 9.33. Daiken Biomedical Co's overall GF Score™ is 23/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Daiken Biomedical Co (TPE:7780), the current Receivables Turnover is 5.42 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Daiken Biomedical Co Ltd is engaged in Research, development, and sales of health food. Its products include fish oil capsules, collagen powder, collagen drinks, natto capsules, and mint leaf capsules. The companies reportable operating segment consists solely of the e-commerce division.
23GF Score
Get the complete analysis for TPE:7780
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:7780 has been successfully added to your 
